Delisting riskPopularity #4,593
GeoVax Labs (GOVX)
Clinical developer of an mpox/smallpox vaccine and gene-directed therapy for head-and-neck cancer.
$0.3699
vs last close+0.01 (+1.82%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 6.69% | 493.2K shares | |
|---|---|---|---|
| 17 holders · as of Jun 30, 2026 | |||
| Insiders | 0.04% | 2.9K shares | |
| 5 holders · as of Aug 8, 2025 | |||
| Other | 93.27% | 6.87M shares | |
| remainder | |||
7.37M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
17 holders · 493.2K shares · 6 new positions · 8 increased · 5 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Jane Street Group, LLC | 315.3K | 4.28% | +315.3Knew | Aug 14, 2026 |
| HRT Financial LP | 126.7K | 1.72% | +126.7Knew | Aug 14, 2026 |
| Geode Capital Management, LLC | 21.1K | 0.29% | −15.0K | Aug 12, 2026 |
| Two Sigma Securities, LLC | 10.7K | 0.14% | +10.7Knew | Aug 14, 2026 |
| Vanguard Fiduciary Trust Co | 5.1K | 0.07% | 0 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 3.5K | 0.05% | −25 | Aug 11, 2026 |
| Vanguard Capital Management LLC | 3.2K | 0.04% | 0 | Aug 13, 2026 |
| Sbi Securities Co., Ltd. | 2.6K | 0.04% | +2.2K | Jul 23, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 291.2K | 13G | May 15, 2026 |
| Mitchell P. Kopin | 9.99% | 233.3K | 13G | May 13, 2026 |
| Ayrton Capital LLC | 9.99% | 4.81M | 13G | Feb 11, 2026 |
| L1 Capital Global Opportunities Master Fund, Ltd. | 5.86% | 13G | Jul 7, 2025 | |
| Jane Street Group, LLC | 5.60% | 292.8K | 13G | Jun 9, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.